Zainal K, Hasyim A, Yamamoto Y, Mizuno T, Sato Y, Rasyid S
Vaccines (Basel). 2024; 12(10).
PMID: 39460322
PMC: 11512279.
DOI: 10.3390/vaccines12101155.
Ciubotariu I, Broyles B, Xie S, Thimmapuram J, Mwenda M, Mambwe B
EBioMedicine. 2024; 106:105227.
PMID: 39018754
PMC: 11663769.
DOI: 10.1016/j.ebiom.2024.105227.
Ciubotariu I, Broyles B, Xie S, Thimmapuram J, Mwenda M, Mambwe B
medRxiv. 2024; .
PMID: 38766239
PMC: 11100930.
DOI: 10.1101/2024.05.11.24307175.
Abuelazm M, Elzeftawy M, Kamal M, Badr H, Gamal M, Aboulgheit M
Infection. 2024; 52(3):707-722.
PMID: 38319556
DOI: 10.1007/s15010-024-02174-4.
Hayashi C, Cao Y, Zavala F, Simonyan H, Young C, Kumar N
Vaccine. 2023; 41(46):6824-6833.
PMID: 37827967
PMC: 11004087.
DOI: 10.1016/j.vaccine.2023.10.009.
Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates.
Nicholas J, De S, Thawornpan P, Brashear A, Kolli S, Subramani P
PLoS Negl Trop Dis. 2023; 17(9):e0011598.
PMID: 37703302
PMC: 10519608.
DOI: 10.1371/journal.pntd.0011598.
A Review of Major Patents on Potential Malaria Vaccine Targets.
Mariano R, Goncalves A, Oliveira D, Ribeiro H, Pereira D, Santos I
Pathogens. 2023; 12(2).
PMID: 36839519
PMC: 9959516.
DOI: 10.3390/pathogens12020247.
Exploring expression and immune potency in mice using mRNA encoding the malaria antigen, CelTOS.
Waghela I, Mallory K, Taylor J, Schneider C, Savransky T, Janse C
Front Immunol. 2023; 13:1026052.
PMID: 36591298
PMC: 9798330.
DOI: 10.3389/fimmu.2022.1026052.
Subcutaneous Immunization with Unaltered Axenic Malaria Parasite Liver Stages Induces Sterile Protection against Infectious Sporozoite Challenge.
Kamil M, Deveci G, Kina U, Kappe S, Aly A
Vaccines (Basel). 2022; 10(11).
PMID: 36366392
PMC: 9695791.
DOI: 10.3390/vaccines10111884.
Computational Clues of Immunogenic Hotspots in Erythrocytic Stage Vaccine Candidate Antigens: In Silico Approach.
Azimi-Resketi M, Heydaryan S, Kumar N, Takalou A, Dizaji R, Gorgani B
Biomed Res Int. 2022; 2022:5886687.
PMID: 36277884
PMC: 9584662.
DOI: 10.1155/2022/5886687.
An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes.
Ouattara A, Dwivedi A, Adams M, Niangaly A, Laurens M, Nyunt M
Microorganisms. 2022; 10(6).
PMID: 35744609
PMC: 9231253.
DOI: 10.3390/microorganisms10061090.
Chemoprophylaxis under sporozoites-lumefantrine (CPS-LMF) immunization induce protective immune responses against sporozoites infection in mice.
Siddiqui A, Bhardwaj J, Hamadou W, Goyal M, Ashraf S, Jahan S
3 Biotech. 2021; 11(11):465.
PMID: 34745816
PMC: 8526652.
DOI: 10.1007/s13205-021-03022-0.
Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection.
Sahu T, Gehrke E, Flores-Garcia Y, Mlambo G, Romano J, Coppens I
NPJ Vaccines. 2021; 6(1):98.
PMID: 34376691
PMC: 8355287.
DOI: 10.1038/s41541-021-00360-1.
In silico identification of novel open reading frames in Plasmodium falciparum oocyte and salivary gland sporozoites using proteogenomics framework.
Gunnarsson S, Prabakaran S
Malar J. 2021; 20(1):71.
PMID: 33546698
PMC: 7866754.
DOI: 10.1186/s12936-021-03598-1.
Diversify and Conquer: The Vaccine Escapism of .
Pance A
Microorganisms. 2020; 8(11).
PMID: 33171746
PMC: 7694999.
DOI: 10.3390/microorganisms8111748.
Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230.
Scaria P, Chen B, Rowe C, Alani N, Muratova O, Barnafo E
Vaccine. 2020; 38(34):5480-5489.
PMID: 32600913
PMC: 11127250.
DOI: 10.1016/j.vaccine.2020.06.018.
Advancements in prophylactic and therapeutic nanovaccines.
Bhardwaj P, Bhatia E, Sharma S, Ahamad N, Banerjee R
Acta Biomater. 2020; 108:1-21.
PMID: 32268235
PMC: 7163188.
DOI: 10.1016/j.actbio.2020.03.020.
Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
Bettencourt P
Front Immunol. 2020; 11:190.
PMID: 32153565
PMC: 7046804.
DOI: 10.3389/fimmu.2020.00190.
Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.
Halbroth B, Sebastian S, Salman A, Ulaszewska M, Gola A, Longley R
Infect Immun. 2019; 88(2).
PMID: 31740525
PMC: 6977128.
DOI: 10.1128/IAI.00573-19.
Vaccination With Sporozoites: Models and Correlates of Protection.
Goh Y, McGuire D, Renia L
Front Immunol. 2019; 10:1227.
PMID: 31231377
PMC: 6560154.
DOI: 10.3389/fimmu.2019.01227.